Published in EMBO J on May 03, 2013
Long Noncoding RNAs in Cancer Pathways. Cancer Cell (2016) 1.63
Transcriptional regulatory functions of nuclear long noncoding RNAs. Trends Genet (2014) 1.36
The long non-coding RNA Paupar regulates the expression of both local and distal genes. EMBO J (2014) 1.19
Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations. Mol Cancer (2013) 1.18
Role of the lncRNA-p53 regulatory network in cancer. J Mol Cell Biol (2014) 1.16
Long noncoding RNAs in cancer: mechanisms of action and technological advancements. Mol Cancer (2016) 1.08
Long noncoding RNAs in cancer: from function to translation. Trends Cancer (2015) 1.06
Negative regulation of the interferon response by an interferon-induced long non-coding RNA. Nucleic Acids Res (2014) 1.02
From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease. Endocr Rev (2014) 0.98
Long non-coding RNAs and their implications in cancer epigenetics. Biosci Rep (2013) 0.95
The structure of human SFPQ reveals a coiled-coil mediated polymer essential for functional aggregation in gene regulation. Nucleic Acids Res (2015) 0.95
An emerging role for long non-coding RNAs in cancer metastasis. Front Genet (2014) 0.95
The bright side of dark matter: lncRNAs in cancer. J Clin Invest (2016) 0.94
Long non-coding RNAs as regulators of the endocrine system. Nat Rev Endocrinol (2015) 0.93
The landscape of antisense gene expression in human cancers. Genome Res (2015) 0.91
Pan-cancer transcriptome analysis reveals long noncoding RNAs with conserved function. RNA Biol (2015) 0.90
Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas. Int J Clin Exp Pathol (2014) 0.90
RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer. Oncotarget (2015) 0.89
Androgen-induced Long Noncoding RNA (lncRNA) SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells. J Biol Chem (2016) 0.87
TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression. Nat Commun (2015) 0.86
Common features of chromatin in aging and cancer: cause or coincidence? Trends Cell Biol (2014) 0.86
Expression analysis of the long non-coding RNA antisense to Uchl1 (AS Uchl1) during dopaminergic cells' differentiation in vitro and in neurochemical models of Parkinson's disease. Front Cell Neurosci (2015) 0.86
Kub5-Hera, the human Rtt103 homolog, plays dual functional roles in transcription termination and DNA repair. Nucleic Acids Res (2014) 0.85
PSF: nuclear busy-body or nuclear facilitator? Wiley Interdiscip Rev RNA (2015) 0.85
Minireview: Long noncoding RNAs: new "links" between gene expression and cellular outcomes in endocrinology. Mol Endocrinol (2013) 0.83
Non-Coding RNAs in Transcriptional Regulation: The review for Current Molecular Biology Reports. Curr Mol Biol Rep (2015) 0.82
Transcriptional gene silencing in humans. Nucleic Acids Res (2016) 0.82
The novel long noncoding RNA linc00467 promotes cell survival but is down-regulated by N-Myc. PLoS One (2014) 0.81
Long noncoding RNAs in prostate cancer: overview and clinical implications. Asian J Androl (2016) 0.81
Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer. Int J Mol Sci (2015) 0.81
The biology of castration-resistant prostate cancer. Curr Probl Cancer (2014) 0.80
Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway. Oncotarget (2016) 0.80
Characterization of DNA binding and pairing activities associated with the native SFPQ·NONO DNA repair protein complex. Biochem Biophys Res Commun (2015) 0.80
Global analysis of biogenesis, stability and sub-cellular localization of lncRNAs mapping to intragenic regions of the human genome. RNA Biol (2015) 0.79
Androgen receptor genomic regulation. Transl Androl Urol (2013) 0.79
Novel RNA markers in prostate cancer: functional considerations and clinical translation. Biomed Res Int (2014) 0.79
Long Noncoding RNAs: At the Intersection of Cancer and Chromatin Biology. Cold Spring Harb Perspect Med (2017) 0.78
Aberrant expression of long noncoding RNAs in cumulus cells isolated from PCOS patients. J Assist Reprod Genet (2015) 0.78
Transcriptional silencing of long noncoding RNA GNG12-AS1 uncouples its transcriptional and product-related functions. Nat Commun (2016) 0.78
Antisense now makes sense: dual modulation of androgen-dependent transcription by CTBP1-AS. EMBO J (2013) 0.78
Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer. Oncotarget (2016) 0.78
Long noncoding RNAs in prostate cancer: mechanisms and applications. Mol Cell Oncol (2014) 0.76
The Long Non-Coding RNA RHPN1-AS1 Promotes Uveal Melanoma Progression. Int J Mol Sci (2017) 0.75
Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy. Cancers (Basel) (2017) 0.75
Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer. Cancers (Basel) (2017) 0.75
Short hairpin RNA library-based functional screening identified ribosomal protein L31 that modulates prostate cancer cell growth via p53 pathway. PLoS One (2014) 0.75
Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer. Int J Mol Sci (2017) 0.75
A new tumor suppressor lncRNA RP11-190D6.2 inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells. Onco Targets Ther (2017) 0.75
Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth. Oncogene (2016) 0.75
Long noncoding RNA linc00598 regulates CCND2 transcription and modulates the G1 checkpoint. Sci Rep (2016) 0.75
Androgen-induced lncRNA POTEF-AS1 regulates apoptosis related pathway to facilitate cell survival in prostate cancer cells. Cancer Sci (2016) 0.75
Long Non-coding RNAs in Urologic Malignancies: Functional Roles and Clinical Translation. J Cancer (2016) 0.75
Down-regulation of long non-coding RNA FOXD3 antisense RNA 1 (FOXD3-AS1) inhibits cell proliferation, migration, and invasion in malignant glioma cells. Am J Transl Res (2016) 0.75
Androgen Receptor Coregulator CTBP1-AS Is Associated With Polycystic Ovary Syndrome in Chinese Women: A Preliminary Study. Reprod Sci (2014) 0.75
Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism. Int J Mol Sci (2015) 0.75
ACSL3 promotes intratumoral steroidogenesis in prostate cancer cells. Cancer Sci (2017) 0.75
Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinoma. Onco Targets Ther (2017) 0.75
An androgen reduced transcript of LncRNA GAS5 promoted prostate cancer proliferation. PLoS One (2017) 0.75
Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF. Proc Natl Acad Sci U S A (2017) 0.75
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2008) 54.83
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature (2009) 35.48
Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell (2007) 30.22
Integrative genomic profiling of human prostate cancer. Cancer Cell (2010) 23.61
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature (2010) 23.55
Molecular determinants of resistance to antiandrogen therapy. Nat Med (2003) 18.90
ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia (2004) 17.08
Antisense transcription in the mammalian transcriptome. Science (2005) 15.69
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res (2006) 9.87
Widespread occurrence of antisense transcription in the human genome. Nat Biotechnol (2003) 8.54
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature (2005) 8.53
Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature (2008) 7.64
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell (2009) 7.09
Tsix, a gene antisense to Xist at the X-inactivation centre. Nat Genet (1999) 6.77
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol (2011) 6.54
Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature (2003) 6.48
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell (2005) 6.04
Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell (2005) 5.38
Mechanisms of androgen-refractory prostate cancer. N Engl J Med (2004) 4.49
A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell (2011) 4.42
Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature (2007) 4.12
Alu element-mediated gene silencing. EMBO J (2008) 3.22
PSF and p54(nrb)/NonO--multi-functional nuclear proteins. FEBS Lett (2002) 3.06
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Br J Cancer (1999) 2.34
Transcriptional regulation by C-terminal binding proteins. Int J Biochem Cell Biol (2007) 2.28
The transcriptional corepressor CtBP: a foe of multiple tumor suppressors. Cancer Res (2009) 2.02
PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors. Mol Cell Biol (2001) 1.85
Clinical significance of p53 alterations in surgically treated prostate cancers. Mod Pathol (2008) 1.51
Binding of mouse VL30 retrotransposon RNA to PSF protein induces genes repressed by PSF: effects on steroidogenesis and oncogenesis. Proc Natl Acad Sci U S A (2004) 1.35
SMAD3 represses androgen receptor-mediated transcription. Cancer Res (2001) 1.32
p53 represses androgen-induced transactivation of prostate-specific antigen by disrupting hAR amino- to carboxyl-terminal interaction. J Biol Chem (2001) 1.30
Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis. Oncogene (2007) 1.28
Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth. Cancer Res (2009) 1.20
Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line. Cancer Res (2001) 1.18
Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells. Oncogene (2010) 1.16
TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer. Mol Endocrinol (2012) 1.15
CtBPs promote cell survival through the maintenance of mitotic fidelity. Mol Cell Biol (2009) 1.12
Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP. Oncogene (2005) 1.12
Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. Prostate (2008) 1.06
Role of transcriptional corepressor CtBP1 in prostate cancer progression. Neoplasia (2012) 1.01
DHT selectively reverses Smad3-mediated/TGF-beta-induced responses through transcriptional down-regulation of Smad3 in prostate epithelial cells. Mol Endocrinol (2010) 0.99
Transcriptional regulation through noncoding RNAs and epigenetic modifications. RNA Biol (2009) 0.92
Analysis for localization of steroid sulfatase in human tissues. Methods Enzymol (2005) 0.79
Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09
Global variation in copy number in the human genome. Nature (2006) 57.50
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature (2007) 37.09
International network of cancer genome projects. Nature (2010) 20.35
Landscape of transcription in human cells. Nature (2012) 20.18
Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet (2006) 17.19
Cohesin mediates transcriptional insulation by CCCTC-binding factor. Nature (2008) 12.01
Empirical analysis of transcriptional activity in the Arabidopsis genome. Science (2003) 11.62
TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature (2007) 8.87
Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage. Proc Natl Acad Sci U S A (2003) 8.73
Copy number variation: new insights in genome diversity. Genome Res (2006) 8.66
Collection, mapping, and annotation of over 28,000 cDNA clones from japonica rice. Science (2003) 8.65
Monitoring the expression profiles of 7000 Arabidopsis genes under drought, cold and high-salinity stresses using a full-length cDNA microarray. Plant J (2002) 7.70
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature (2006) 7.56
Integrative annotation of 21,037 human genes validated by full-length cDNA clones. PLoS Biol (2004) 7.17
Genome assembly comparison identifies structural variants in the human genome. Nat Genet (2006) 6.93
Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet (2003) 6.69
Avian flu: isolation of drug-resistant H5N1 virus. Nature (2005) 6.66
The Drosophila gene collection: identification of putative full-length cDNAs for 70% of D. melanogaster genes. Genome Res (2002) 6.61
A promoter-level mammalian expression atlas. Nature (2014) 6.25
An atlas of combinatorial transcriptional regulation in mouse and man. Cell (2010) 6.24
Functional annotation of a full-length Arabidopsis cDNA collection. Science (2002) 6.15
Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature (2004) 6.11
The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat Genet (2009) 6.02
Genome-wide detection of human copy number variations using high-density DNA oligonucleotide arrays. Genome Res (2006) 5.97
Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol (2006) 5.82
The regulated retrotransposon transcriptome of mammalian cells. Nat Genet (2009) 5.79
Mammalian RNA polymerase II core promoters: insights from genome-wide studies. Nat Rev Genet (2007) 5.75
High-throughput mapping of a dynamic signaling network in mammalian cells. Science (2005) 5.21
Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe (2009) 5.12
CAGE: cap analysis of gene expression. Nat Methods (2006) 5.04
Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome. Genome Res (2005) 4.86
Buonocore memorial lecture. Adhesion to enamel and dentin: current status and future challenges. Oper Dent (2003) 4.75
Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet (2013) 4.61
Tiny RNAs associated with transcription start sites in animals. Nat Genet (2009) 4.19
Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene (2006) 4.13
Comprehensive analysis of NAC family genes in Oryza sativa and Arabidopsis thaliana. DNA Res (2003) 4.01
Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics (2005) 3.92
Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell (2012) 3.90
An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene. Nature (2003) 3.90
High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet (2011) 3.86
Complex Loci in human and mouse genomes. PLoS Genet (2006) 3.74
TagDust--a program to eliminate artifacts from next generation sequencing data. Bioinformatics (2009) 3.64
A two-step method for marking polypectomy sites in the colon and rectum. Gastrointest Endosc (2003) 3.63
Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol (2009) 3.58
Targeting a complex transcriptome: the construction of the mouse full-length cDNA encyclopedia. Genome Res (2003) 3.50
The reality of pervasive transcription. PLoS Biol (2011) 3.41
Antisense transcripts with FANTOM2 clone set and their implications for gene regulation. Genome Res (2003) 3.40
Hidden layers of human small RNAs. BMC Genomics (2008) 3.31
The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol (2008) 3.30
Magnitude and role of wall shear stress on cerebral aneurysm: computational fluid dynamic study of 20 middle cerebral artery aneurysms. Stroke (2004) 3.21
Impact of alternative initiation, splicing, and termination on the diversity of the mRNA transcripts encoded by the mouse transcriptome. Genome Res (2003) 3.21
A rescue strategy for multimapping short sequence tags refines surveys of transcriptional activity by CAGE. Genomics (2008) 3.19
Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J (2002) 3.06
Small RNAs derived from snoRNAs. RNA (2009) 3.04
An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature (2009) 3.04
IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol (2005) 3.02
Rapid detection of epidermal growth factor receptor mutations in lung cancer by the SMart-Amplification Process. Clin Cancer Res (2007) 3.02
Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas. Clin Cancer Res (2005) 2.97
A comprehensive survey of 3' animal miRNA modification events and a possible role for 3' adenylation in modulating miRNA targeting effectiveness. Genome Res (2010) 2.87
Methods for analyzing deep sequencing expression data: constructing the human and mouse promoterome with deepCAGE data. Genome Biol (2009) 2.86
MafA is a key regulator of glucose-stimulated insulin secretion. Mol Cell Biol (2005) 2.85
Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem Biophys Res Commun (2005) 2.85
RNAdb--a comprehensive mammalian noncoding RNA database. Nucleic Acids Res (2005) 2.84
CARAT: a novel method for allelic detection of DNA copy number changes using high density oligonucleotide arrays. BMC Bioinformatics (2006) 2.82
Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest (2007) 2.81
Deletion of the selection cassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals Flk1 expression in multipotent mesodermal progenitors. Blood (2005) 2.76
Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem (2004) 2.72
A code for transcription initiation in mammalian genomes. Genome Res (2007) 2.71
Direct metagenomic detection of viral pathogens in nasal and fecal specimens using an unbiased high-throughput sequencing approach. PLoS One (2009) 2.67
Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem (2004) 2.66
Genome-wide analysis of cancer/testis gene expression. Proc Natl Acad Sci U S A (2008) 2.66
Identification of putative noncoding RNAs among the RIKEN mouse full-length cDNA collection. Genome Res (2003) 2.63
Genome-wide detection and analysis of hippocampus core promoters using DeepCAGE. Genome Res (2008) 2.60
Monitoring the expression pattern of around 7,000 Arabidopsis genes under ABA treatments using a full-length cDNA microarray. Funct Integr Genomics (2002) 2.59
Genomic-scale prioritization of drug targets: the TDR Targets database. Nat Rev Drug Discov (2008) 2.58
Architectural roles of multiple chromatin insulators at the human apolipoprotein gene cluster. EMBO J (2009) 2.56
CAGE Basic/Analysis Databases: the CAGE resource for comprehensive promoter analysis. Nucleic Acids Res (2006) 2.54
Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet (2006) 2.51
Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res (2002) 2.49